Tomioka Ryota, Ogata Kosuke, Ishihama Yasushi
Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.
Shionogi & Co., Ltd., Pharmaceutical Technology Research Division, Toyonaka, Osaka 561-0825, Japan.
Mass Spectrom (Tokyo). 2024;13(1):A0152. doi: 10.5702/massspectrometry.A0152. Epub 2024 Sep 14.
Host cell protein (HCP) impurities are considered a critical quality attribute of biopharmaceuticals because of their potential to compromise safety and efficacy, and LC/MS-based analytical methods have been developed to identify and quantify individual proteins instead of employing enzyme-linked immunosorbent assay to assess total HCP levels. Native digestion enables highly sensitive detection of HCPs but requires overnight incubation to generate peptides, limiting the throughput of sample preparation. In this study, we developed an approach employing native digestion on a trypsin-immobilized column to improve the sensitivity and throughput. We examined suitable databases for the identification of HCPs derived from Chinese hamster ovary (CHO) cells and selected RefSeq's Chinese Hamster as the optimal database. Then, we investigated methods to identify HCPs with greater efficiency than that of denatured in-solution digestion. Native in-column digestion not only reduced the digestion time from overnight to 10 min but also increased the number of quantified HCPs from 154 to 226. In addition to this rapid digestion methodology, we developed high-throughput LC/MS/MS with a monolithic silica column and parallel reaction monitoring-parallel accumulation-serial fragmentation. The optimized system was validated with synthetic peptides derived from high-risk HCPs, confirming excellent linearity, precision, accuracy, and low limit of detection (LOD) and limit of quantification (LOQ) (1-3 ppm). The optimized digestion and analysis method enabled high-throughput quantification of HCPs, and is expected to be useful for quality control and characterization of HCPs in antibody drugs.
宿主细胞蛋白(HCP)杂质被认为是生物制药的关键质量属性,因为它们可能会影响安全性和有效性,并且基于液相色谱/质谱的分析方法已被开发用于识别和定量单个蛋白质,而不是采用酶联免疫吸附测定来评估总HCP水平。天然酶解能够高度灵敏地检测HCP,但需要过夜孵育以生成肽段,这限制了样品制备的通量。在本研究中,我们开发了一种在固定化胰蛋白酶柱上进行天然酶解的方法,以提高灵敏度和通量。我们研究了适合鉴定源自中国仓鼠卵巢(CHO)细胞的HCP的数据库,并选择RefSeq的中国仓鼠作为最佳数据库。然后,我们研究了比变性溶液内酶解更高效地鉴定HCP的方法。柱上天然酶解不仅将酶解时间从过夜缩短至10分钟,还将定量的HCP数量从154个增加到226个。除了这种快速酶解方法外,我们还开发了使用整体硅胶柱和并行反应监测 - 并行累积 - 串行碎裂的高通量液相色谱/串联质谱法。优化后的系统用源自高风险HCP的合成肽进行了验证,证实具有出色的线性、精密度、准确度以及低检测限(LOD)和定量限(LOQ)(1 - 3 ppm)。优化后的酶解和分析方法能够对HCP进行高通量定量,预计对抗体药物中HCP的质量控制和表征有用。